In another study, genetic modulation of the let-7 miRNA binding to the KRAS 3′-untranslated region was found to correlate with survival of metastatic colorectal cancer patients who underwent salvage cetuximab-irinotecan therapy [38]. The gene discussed is KRAS; the disease is metastatic colorectal cancer.